Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings and sales for the third quarter of 2020. The company’s stock gained early Tuesday immediately after the announcement.
Worldwide sales edged up 1% year-over-year to $12.55 billion and far exceeded expectations. Excluding foreign exchange impacts, sales grew 2%. The top-line benefitted from strength in the oncology and human health vaccines.
Net earnings, on an adjusted basis, rose to $1.74 per share from $1.51 per share in the third quarter of 2019 and surpassed the market’s forecast.
Unadjusted net income advanced to $2.94 billion or $1.16 per share from $1.90 billion or $0.74 per share last year.
Shares of the company gained during Tuesday’s premarket trading, after closing the previous session lower.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Video game retailer GameStop Corp. (NYSE: GME), which has become the talk of the town after the unprecedented stock rally in recent weeks, reported a narrower loss for the first
The steel industry managed to shrug off the pandemic blues earlier than expected as the recovery in industrial activity pushed up demand. With the vaccination drive and the government’s aggressive
Campbell Soup Company (NYSE: CPB) reported third-quarter 2021 earnings results today. Net sales decreased 11% year-over-year to $1.98 billion, as a result of lapping the demand surge at the onset